Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil plus Solifenacin vs Tamsulosin plus Solifenacin for BPH/OAB
NCT05494567Phase 4Unknown
- Sponsor
- Mansoura University
- Start
- Nov 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tadalafil in benign prostatic hyperplasia (BPH), overactive bladder (OAB), sponsored by Mansoura University. Status: unknown.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)overactive bladder (OAB)
Beyond the preview
Go deeper on NCT05494567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05494567.